Efficacy of sacubitril-valsartan compared with angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker for preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
Circulation; 148 (Suppl.1), 2023
INTRODUCTION: Among patients with atrial fibrillation (AF) who underwent catheter ablation, it is unclear whether AF recurrence is lower in those who receive Sacubitril-Valsartan (SV) than in those who receive ACEi (angiotensin-converting enzyme inhibitor) or ARB (angiotensin-receptor blocker). Hypothesi...